Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

There could be a new use for semaglutide, the main ingredient of weight loss and diabetes drugs Wegovy and Ozempic. Dr. Jon ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ — 63%, compared with 34% of those taking a placebo, researchers reported ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A study has found that Ozempic may reverse signs of a disease that contributes to 2,000,000 deaths per year. New research has ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.